Phase II Prospective Study of CYP2D6 Activity in Patients With Metastatic or Recurrent Breast Cancer Treated With Tamoxifen Citrate (No Drugs Provided)
ECOG E3108  (MBMC Contact: Chris Joyce 314-996-5536)  Click For Consent ***

***Available through CTSU

← Previous